The companies signed a license and development agreement for an oral cardiovascular product incorporating ETHCY's Multipor sustained release technology, a system that controls the release of drugs through variance in porosity and thickness of a...
The companies signed a license and development agreement for an oral cardiovascular product incorporating ETHCY's Multipor sustained release technology, a system that controls the release of drugs through variance in porosity and thickness of a...